TCG Crossover GP II, LLC 13D and 13G filings for Tango Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:24 pm Sale | 2026-03-31 | 13G | TANGO THERAPEUTICS INC TNGX | TCG Crossover GP II, LLC | 11,597,737 8.100% | -1,924,102 (-14.23%) | Filing |
| 2026-02-17 4:22 pm Purchase | 2025-12-31 | 13G | TANGO THERAPEUTICS INC TNGX | TCG Crossover GP II, LLC | 13,521,839 9.990% | 4,985,643 (+58.41%) | Filing |
| 2025-11-14 4:23 pm Sale | 2025-09-30 | 13G | TANGO THERAPEUTICS INC TNGX | TCG Crossover GP II, LLC | 8,536,196 6.300% | -1,964,416 (-18.71%) | Filing |
| 2024-11-20 4:24 pm Purchase | 2024-11-13 | 13G | TANGO THERAPEUTICS INC TNGX | TCG Crossover GP II, LLC | 10,500,612 9.800% | 10,500,612 (New Position) | Filing |